CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative ...
1d
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer
CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance maladie du ...
One in six laboratory-confirmed bacteria in 2023 proved resistant to antibiotic treatment, according to the World Health ...
Toasted skin syndrome causes a net-like rash to appear where the skin has been exposed to a heat source. It may resolve on ...
Q2 2026 Earnings Call Transcript October 27, 2025 Operator: Greetings, and welcome to the SIFI Technologies Financial Results ...
What we’re doing is working but it’s not good enough,” CEO Philipp Navratil told investors during the CPG major’s Q3 FY25 ...
The news on vaccines was not so good, as declining sales of shingles shot Shingrix in the US and China pegged back growth to ...
13d
I-Mab (IMAB) Discusses Business Transformation Strategy and Plans for Accelerated Growth Transcript
Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...
Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback